Pharvaris N.V. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was EUR 23.6 million compared to EUR 8.49 million a year ago. Basic loss per share from continuing operations was EUR 0.58 compared to EUR 0.25 a year ago.
For the nine months, net loss was EUR 68.13 million compared to EUR 37.14 million a year ago. Basic loss per share from continuing operations was EUR 1.87 compared to EUR 1.11 a year ago.